<DOC>
	<DOC>NCT01435967</DOC>
	<brief_summary>The aim of this study is to monitor any impact in the change from the lyophilised formulation to the liquid formulation of the Rotarix™ vaccine on hospitalisations for rotavirus gastroenteritis. This is planned to be assessed by comparing trends of hospitalisations due to laboratory confirmed rotavirus gastroenteritis in children &lt;=5 years of age, before and after introduction of the liquid formulation of the vaccine in Belgium.</brief_summary>
	<brief_title>Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<criteria>All subjects must satisfy ALL the following criteria at study entry: Child aged ≤5 years with opportunity to receive lyophilised or liquid formulation of Rotarix™; Hospitalised at one of the participating centres in Belgium; A stool sample has been provided for a rotavirus detection test during the study period; Laboratory test result of rotavirus is available. • None.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Rotarix™</keyword>
	<keyword>Observational</keyword>
	<keyword>ecological</keyword>
</DOC>